Companies House 2023-06-19 2024-06-30 2024-06-30 false true iso4217:GBP xbrli:pure 14943730 2024-06-30 14943730 2023-06-19 2024-06-30 14943730 curr:PoundSterling 2023-06-19 2024-06-30 14943730 uk-bus:PrivateLimitedCompanyLtd 2023-06-19 2024-06-30 14943730 uk-bus:FRS102 2023-06-19 2024-06-30 14943730 uk-bus:AuditExempt-NoAccountantsReport 2023-06-19 2024-06-30 14943730 uk-bus:AbridgedAccounts 2023-06-19 2024-06-30 14943730 uk-bus:RegisteredOffice 2023-06-19 2024-06-30 14943730 uk-bus:Director40 2023-06-19 2024-06-30 14943730 uk-bus:Director1 2023-06-19 2024-06-30 14943730 uk-bus:Director2 2023-06-19 2024-06-30 14943730 uk-bus:Director3 2023-06-19 2024-06-30 14943730 uk-bus:Director4 2023-06-19 2024-06-30 14943730 uk-bus:Director5 2023-06-19 2024-06-30 14943730 uk-bus:Director6 2023-06-19 2024-06-30 14943730 uk-bus:Director7 2023-06-19 2024-06-30 14943730 uk-bus:Director8 2023-06-19 2024-06-30 14943730 uk-bus:Director9 2023-06-19 2024-06-30 14943730 uk-bus:Director10 2023-06-19 2024-06-30 14943730 uk-bus:Director11 2023-06-19 2024-06-30 14943730 uk-bus:Director12 2023-06-19 2024-06-30 14943730 uk-bus:Director13 2023-06-19 2024-06-30 14943730 uk-bus:Director14 2023-06-19 2024-06-30 14943730 uk-bus:Director15 2023-06-19 2024-06-30 14943730 uk-bus:Director16 2023-06-19 2024-06-30 14943730 uk-bus:Director17 2023-06-19 2024-06-30 14943730 uk-bus:Director18 2023-06-19 2024-06-30 14943730 uk-bus:Director19 2023-06-19 2024-06-30 14943730 uk-bus:Director20 2023-06-19 2024-06-30 14943730 uk-bus:CompanySecretary1 2023-06-19 2024-06-30 14943730 core:AfterOneYear 2024-06-30 14943730 core:WithinOneYear 2024-06-30 14943730 core:WithinOneYear 2023-06-19 2024-06-30 14943730 core:AfterOneYear 2024-06-30 14943730 core:AfterOneYear 2023-06-19 2024-06-30 14943730 core:ShareCapital 2024-06-30 14943730 core:SharePremium 2024-06-30 14943730 core:OtherReservesSubtotal 2024-06-30 14943730 core:RevaluationReserve 2024-06-30 14943730 core:RetainedEarningsAccumulatedLosses 2024-06-30 14943730 core:Associate1 2023-06-19 2024-06-30 14943730 core:Associate1 2024-06-30 14943730 core:Associate2 2023-06-19 2024-06-30 14943730 core:Associate2 2024-06-30 14943730 core:Associate3 2023-06-19 2024-06-30 14943730 core:Associate3 2024-06-30 14943730 core:Associate4 2023-06-19 2024-06-30 14943730 core:Associate4 2024-06-30 14943730 core:Associate5 2023-06-19 2024-06-30 14943730 core:Associate5 2024-06-30 14943730 core:Associate6 2023-06-19 2024-06-30 14943730 core:Associate6 2024-06-30 14943730 core:Associate7 2023-06-19 2024-06-30 14943730 core:Associate7 2024-06-30 14943730 core:Associate8 2023-06-19 2024-06-30 14943730 core:Associate8 2024-06-30 14943730 core:Associate9 2023-06-19 2024-06-30 14943730 core:Associate9 2024-06-30 14943730 core:Associate10 2023-06-19 2024-06-30 14943730 core:Associate10 2024-06-30 14943730 core:Associate11 2023-06-19 2024-06-30 14943730 core:Associate11 2024-06-30 14943730 core:Associate12 2023-06-19 2024-06-30 14943730 core:Associate12 2024-06-30 14943730 core:Associate13 2023-06-19 2024-06-30 14943730 core:Associate13 2024-06-30 14943730 core:Associate14 2023-06-19 2024-06-30 14943730 core:Associate14 2024-06-30 14943730 core:Associate15 2023-06-19 2024-06-30 14943730 core:Associate15 2024-06-30 14943730 core:Associate16 2023-06-19 2024-06-30 14943730 core:Associate16 2024-06-30 14943730 core:Associate17 2023-06-19 2024-06-30 14943730 core:Associate17 2024-06-30 14943730 core:Associate18 2023-06-19 2024-06-30 14943730 core:Associate18 2024-06-30 14943730 core:Associate19 2023-06-19 2024-06-30 14943730 core:Associate19 2024-06-30 14943730 core:Associate20 2023-06-19 2024-06-30 14943730 core:Associate20 2024-06-30 14943730 core:Associate1 2023-06-19 2024-06-30 14943730 core:Associate2 2023-06-19 2024-06-30 14943730 core:Associate3 2023-06-19 2024-06-30 14943730 core:Associate4 2023-06-19 2024-06-30 14943730 core:Associate5 2023-06-19 2024-06-30 14943730 core:Associate6 2023-06-19 2024-06-30 14943730 core:Associate7 2023-06-19 2024-06-30 14943730 core:Associate8 2023-06-19 2024-06-30 14943730 core:Associate9 2023-06-19 2024-06-30 14943730 core:Associate10 2023-06-19 2024-06-30 14943730 core:Associate11 2023-06-19 2024-06-30 14943730 core:Associate12 2023-06-19 2024-06-30 14943730 core:Associate13 2023-06-19 2024-06-30 14943730 core:Associate14 2023-06-19 2024-06-30 14943730 core:Associate15 2023-06-19 2024-06-30 14943730 core:Associate16 2023-06-19 2024-06-30 14943730 core:Associate17 2023-06-19 2024-06-30 14943730 core:Associate18 2023-06-19 2024-06-30 14943730 core:Associate19 2023-06-19 2024-06-30 14943730 core:Associate20 2023-06-19 2024-06-30 14943730 uk-bus:Director1 1 2023-06-19 2024-06-30 14943730 uk-bus:Director1 1 2024-06-30 14943730 uk-bus:Director2 2 2023-06-19 2024-06-30 14943730 uk-bus:Director2 2 2024-06-30 14943730 uk-bus:Director1 3 2023-06-19 2024-06-30 14943730 uk-bus:Director1 3 2024-06-30 14943730 uk-bus:Director4 4 2023-06-19 2024-06-30 14943730 uk-bus:Director4 4 2024-06-30 14943730 uk-bus:Director5 5 2023-06-19 2024-06-30 14943730 uk-bus:Director5 5 2024-06-30 14943730 uk-bus:Director6 6 2023-06-19 2024-06-30 14943730 uk-bus:Director6 6 2024-06-30 14943730 uk-bus:Director7 7 2023-06-19 2024-06-30 14943730 uk-bus:Director7 7 2024-06-30 14943730 uk-bus:Director8 8 2023-06-19 2024-06-30 14943730 uk-bus:Director8 8 2024-06-30 14943730 uk-bus:Director9 9 2023-06-19 2024-06-30 14943730 uk-bus:Director9 9 2024-06-30 14943730 uk-bus:Director10 10 2023-06-19 2024-06-30 14943730 uk-bus:Director10 10 2024-06-30 14943730 uk-bus:Director11 11 2023-06-19 2024-06-30 14943730 uk-bus:Director11 11 2024-06-30 14943730 uk-bus:Director12 12 2023-06-19 2024-06-30 14943730 uk-bus:Director12 12 2024-06-30 14943730 uk-bus:Director13 13 2023-06-19 2024-06-30 14943730 uk-bus:Director13 13 2024-06-30 14943730 uk-bus:Director14 14 2023-06-19 2024-06-30 14943730 uk-bus:Director14 14 2024-06-30 14943730 uk-bus:Director15 15 2023-06-19 2024-06-30 14943730 uk-bus:Director15 15 2024-06-30 14943730 uk-bus:Director16 16 2023-06-19 2024-06-30 14943730 uk-bus:Director16 16 2024-06-30 14943730 uk-bus:Director17 17 2023-06-19 2024-06-30 14943730 uk-bus:Director17 17 2024-06-30 14943730 uk-bus:Director18 18 2023-06-19 2024-06-30 14943730 uk-bus:Director18 18 2024-06-30 14943730 uk-bus:Director19 19 2023-06-19 2024-06-30 14943730 uk-bus:Director19 19 2024-06-30 14943730 uk-bus:Director20 20 2023-06-19 2024-06-30 14943730 uk-bus:Director20 20 2024-06-30 14943730 1 2023-06-19 2024-06-30 14943730 2 2023-06-19 2024-06-30 14943730 3 2023-06-19 2024-06-30

# ACCRINGTON HEALTH SUITE LTD

## Company Registration Number:
14943730 (England and Wales)

## Unaudited abridged accounts for the year ended 30 June 2024

## Period of accounts

## Start date: 19 June 2023

## End date: 30 June 2024

# ACCRINGTON HEALTH SUITE LTD

## Contents of the Financial Statements

for the Period Ended 30 June 2024

Balance sheet |
Notes |

# ACCRINGTON HEALTH SUITE LTD

## Balance sheet

As at 30 June 2024

| Notes | 2024
--- | --- | ---
|  | £
Fixed assets
Intangible assets: | 3 | 190,000
Tangible assets: | 4 | 24,898
Total fixed assets: |  | 214,898
Current assets
Debtors: |  | 41,369
Cash at bank and in hand: |  | 216,044
Total current assets: |  | 257,413
Creditors: amounts falling due within one year: | 5 | (239,188)
Net current assets (liabilities): |  | 18,225
Total assets less current liabilities: |  | 233,123
Creditors: amounts falling due after more than one year: |  | (10,150)
Total net assets (liabilities): |  | 222,973
Capital and reserves
Called up share capital: |  | 100
Profit and loss account: |  | 222,873
Shareholders funds: |  | 222,973

The notes form part of these financial statements

# ACCRINGTON HEALTH SUITE LTD

## Balance sheet statements

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 12 May 2025
and signed on behalf of the board by:

Name: MR M TAHIR
Status: Director

The notes form part of these financial statements

# ACCRINGTON HEALTH SUITE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2024

## 1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

# ACCRINGTON HEALTH SUITE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2024

## 2. Employees

| 2024
--- | ---
Average number of employees during the period | 5

# ACCRINGTON HEALTH SUITE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2024

## 3. Intangible Assets

| Total
--- | ---
Cost | £
Additions | 200,000
At 30 June 2024 | 200,000
Amortisation |
Charge for year | 10,000
At 30 June 2024 | 10,000
Net book value |
At 30 June 2024 | 190,000

Intangible fixed assets are measured at cost less accumulative amortisation and any accumulative impairment losses

# ACCRINGTON HEALTH SUITE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2024

## 4. Tangible Assets

| Total
--- | ---
Cost | £
Additions | 31,122
At 30 June 2024 | 31,122
Depreciation |
Charge for year | 6,224
At 30 June 2024 | 6,224
Net book value |
At 30 June 2024 | 24,898

# ACCRINGTON HEALTH SUITE LTD

## Notes to the Financial Statements

for the Period Ended 30 June 2024

## 5. Creditors: amounts falling due within one year note

Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method